{"title":"PIM1 protects pancreatic ductal cancer cells from glucose deprivation-induced oxidative stress via OXR1 phosphorylation","authors":"Jinjing Wang , Weidong Yu , Shuxin Cai , Huanxin Wei , Bilu Peng , Jiazi Qian , Yu Chen , Fulong Zheng , Huihui Jiang , Qipeng Xie , Huaibin Zhou , Hezhi Fang , Jianxin Lyu","doi":"10.1016/j.bbadis.2025.168031","DOIUrl":null,"url":null,"abstract":"<div><div>Limited nutrient availability in pancreatic ductal adenocarcinoma (PDAC), due to its dense extracellular matrix, presents a significant metabolic challenge that tumor cells must overcome to survive oxidative stress-induced cell death. Here, we found that PIM1, a serine/threonine kinase, is upregulated in PDAC tumors and serves as a poor prognostic indicator. Although PIM1 does not significantly affect PDAC cell proliferation, it is essential for protecting cells from glucose deprivation-induced cell death. Mechanistically, PIM1 interacts with the antioxidant protein OXR1 (oxidation resistance protein 1) and promotes its phosphorylation at serine 91. This modification mitigates oxidative stress, preserves mitochondrial morphology, and ultimately protects PDAC cells from glucose deprivation-induced cell death. Moreover, glucose deprivation activates AMPK, which in turn stabilizes PIM1 by protecting it from ubiquitin-mediated protein degradation. In contrast, AMPK inhibition reduces PIM1 level and abolishes the survival difference between cells with and without PIM1 depletion. Collectively, our findings reveal a critical role of PIM1 in PDAC cell survival under nutrient stress and identify PIM1 as a potential therapeutic target for PDAC.</div></div>","PeriodicalId":8821,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":"1872 1","pages":"Article 168031"},"PeriodicalIF":4.2000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochimica et biophysica acta. Molecular basis of disease","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0925443925003795","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Limited nutrient availability in pancreatic ductal adenocarcinoma (PDAC), due to its dense extracellular matrix, presents a significant metabolic challenge that tumor cells must overcome to survive oxidative stress-induced cell death. Here, we found that PIM1, a serine/threonine kinase, is upregulated in PDAC tumors and serves as a poor prognostic indicator. Although PIM1 does not significantly affect PDAC cell proliferation, it is essential for protecting cells from glucose deprivation-induced cell death. Mechanistically, PIM1 interacts with the antioxidant protein OXR1 (oxidation resistance protein 1) and promotes its phosphorylation at serine 91. This modification mitigates oxidative stress, preserves mitochondrial morphology, and ultimately protects PDAC cells from glucose deprivation-induced cell death. Moreover, glucose deprivation activates AMPK, which in turn stabilizes PIM1 by protecting it from ubiquitin-mediated protein degradation. In contrast, AMPK inhibition reduces PIM1 level and abolishes the survival difference between cells with and without PIM1 depletion. Collectively, our findings reveal a critical role of PIM1 in PDAC cell survival under nutrient stress and identify PIM1 as a potential therapeutic target for PDAC.
期刊介绍:
BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease. This journal covers aspects of aging, cancer, metabolic-, neurological-, and immunological-based disease. Manuscripts focused on using animal models to elucidate biochemical and mechanistic insight in each of these conditions, are particularly encouraged. Manuscripts should emphasize the underlying mechanisms of disease pathways and provide novel contributions to the understanding and/or treatment of these disorders. Highly descriptive and method development submissions may be declined without full review. The submission of uninvited reviews to BBA - Molecular Basis of Disease is strongly discouraged, and any such uninvited review should be accompanied by a coverletter outlining the compelling reasons why the review should be considered.